Kineta, Inc. (KANT)
OTCMKTS · Delayed Price · Currency is USD
0.3361
+0.0461 (15.90%)
Inactive · Last trade price on Jun 27, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
Next-generation Immunotherapies
5.44M
Log In
Log In
Log In
Next-generation Immunotherapies Growth
178.65%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
United States
5.44M
Log In
Log In
Log In
United States Growth
178.65%
Log In
Log In
Log In